busulfan has been researched along with Disease, Pulmonary in 45 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Busulfan (Bu)-based preparative regimens have not been extensively investigated in Hodgkin disease (HD)." | 7.73 | Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. ( Andrèsen, S; Avalos, B; Bolwell, B; Copelan, E; Elder, P; Farag, S; Kalaycio, M; Lin, T; Marcucci, G; Penza, S; Pohlman, B; Sobecks, R; Wadehra, N, 2006) |
| "A 32-year-old Japanese man with chronic granulocytic leukemia died of respiratory failure." | 5.28 | Pulmonary alveolar proteinosis and disseminated atypical mycobacteriosis in a patient with busulfan lung. ( Hirose, N; Miake, S; Nagata, N; Shigematsu, N; Sueishi, K; Tanaka, K; Watanabe, K; Yoshida, M, 1990) |
| "Busulfan (Bu)-based preparative regimens have not been extensively investigated in Hodgkin disease (HD)." | 3.73 | Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. ( Andrèsen, S; Avalos, B; Bolwell, B; Copelan, E; Elder, P; Farag, S; Kalaycio, M; Lin, T; Marcucci, G; Penza, S; Pohlman, B; Sobecks, R; Wadehra, N, 2006) |
| "Diffuse pulmonary diseases seen in patients receiving chemotherapy have a wide variety of etiologies including infection, involvement with the underlying disease, injury from radiation or diagnostic agents, and toxicity from chemotherapeutic drugs." | 2.36 | Review: diagnosis of chemotherapy lung. ( Gamsu, G; Putman, CE; Sostman, HD, 1981) |
| "Drug-induced pulmonary disease is an infrequent, but clinically significant, toxic manifestation of antineoplastic drug therapy." | 2.36 | Pulmonary toxicity of antineoplastic drugs. ( Willson, JK, 1978) |
| "Busulfan dose was 16 mg/kg given over 4 days." | 1.29 | Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. ( Czyzewski, EA; Ghalie, R; Hartsell, WF; Kaizer, H, 1995) |
| "A 32-year-old Japanese man with chronic granulocytic leukemia died of respiratory failure." | 1.28 | Pulmonary alveolar proteinosis and disseminated atypical mycobacteriosis in a patient with busulfan lung. ( Hirose, N; Miake, S; Nagata, N; Shigematsu, N; Sueishi, K; Tanaka, K; Watanabe, K; Yoshida, M, 1990) |
| "The busulfan was discontinued and therapy was changed to hydroxyurea." | 1.26 | Early detection of busulfan lung: report of a case. ( Manning, DM; Strimlan, CV; Turbiner, EH, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (75.56) | 18.7374 |
| 1990's | 4 (8.89) | 18.2507 |
| 2000's | 3 (6.67) | 29.6817 |
| 2010's | 4 (8.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagou, K | 1 |
| Ukai, S | 1 |
| Adachi, Y | 1 |
| Fukushima, N | 1 |
| Ozeki, K | 1 |
| Kohno, A | 1 |
| Yu, ZP | 1 |
| Ding, JH | 1 |
| Chen, BA | 1 |
| Li, YF | 1 |
| Ding, BH | 1 |
| Qian, J | 1 |
| Dirou, S | 1 |
| Malard, F | 1 |
| Chambellan, A | 1 |
| Chevallier, P | 1 |
| Germaud, P | 1 |
| Guillaume, T | 1 |
| Delaunay, J | 1 |
| Moreau, P | 1 |
| Delasalle, B | 1 |
| Lemarchand, P | 1 |
| Mohty, M | 1 |
| Majzner, R | 1 |
| Sandoval, C | 1 |
| Dozor, AJ | 1 |
| Jin, Z | 1 |
| van de Ven, C | 1 |
| Dalal, R | 1 |
| Morris, E | 1 |
| Harrison, L | 1 |
| Wolownik, K | 1 |
| Fabricatore, S | 1 |
| Baxter-Lowe, LA | 1 |
| Cairo, MS | 1 |
| Limper, AH | 2 |
| Wadehra, N | 1 |
| Farag, S | 1 |
| Bolwell, B | 1 |
| Elder, P | 1 |
| Penza, S | 1 |
| Kalaycio, M | 1 |
| Avalos, B | 1 |
| Pohlman, B | 1 |
| Marcucci, G | 1 |
| Sobecks, R | 1 |
| Lin, T | 1 |
| Andrèsen, S | 1 |
| Copelan, E | 1 |
| Sostman, HD | 2 |
| Putman, CE | 2 |
| Gamsu, G | 1 |
| Bargon, G | 1 |
| Dalri, P | 1 |
| Piscioli, F | 1 |
| Detassis, C | 1 |
| Manning, DM | 1 |
| Strimlan, CV | 1 |
| Turbiner, EH | 1 |
| Altus, P | 1 |
| Andrew, CC | 1 |
| Lund, MB | 1 |
| Kongerud, J | 1 |
| Brinch, L | 1 |
| Evensen, SA | 1 |
| Boe, J | 1 |
| Hartsell, WF | 1 |
| Czyzewski, EA | 1 |
| Ghalie, R | 1 |
| Kaizer, H | 1 |
| Rosenow, EC | 2 |
| Socié, G | 1 |
| Clift, RA | 1 |
| Blaise, D | 1 |
| Devergie, A | 1 |
| Ringden, O | 1 |
| Martin, PJ | 1 |
| Remberger, M | 1 |
| Deeg, HJ | 1 |
| Ruutu, T | 1 |
| Michallet, M | 1 |
| Sullivan, KM | 1 |
| Chevret, S | 1 |
| Matthay, RA | 1 |
| Schein, PS | 1 |
| Winokur, SH | 1 |
| Lippmann, M | 1 |
| Obrist, R | 1 |
| Obrecht, JP | 1 |
| Willson, JK | 1 |
| Medici, TC | 1 |
| Miyashita, T | 1 |
| Ojima, A | 1 |
| Tuji, T | 1 |
| Tajima, T | 1 |
| Watanabe, K | 2 |
| Jaffe, N | 1 |
| Kobayashi, I | 1 |
| Didisheim, P | 1 |
| Sueishi, K | 1 |
| Tanaka, K | 1 |
| Nagata, N | 1 |
| Hirose, N | 1 |
| Shigematsu, N | 1 |
| Miake, S | 1 |
| Yoshida, M | 1 |
| Luisetti, M | 1 |
| Peona, V | 1 |
| Salmona, M | 1 |
| Pagnoni, AM | 1 |
| Villani, F | 1 |
| Knerich, R | 1 |
| Genghini, M | 1 |
| Abbà, L | 1 |
| Pozzi, E | 1 |
| Hartmann, O | 1 |
| Benhamou, E | 1 |
| Beaujean, F | 1 |
| Pico, JL | 1 |
| Kalifa, C | 1 |
| Patte, C | 1 |
| Flamant, F | 1 |
| Lemerle, J | 1 |
| Whitcomb, ME | 2 |
| Schwarz, MI | 1 |
| Goldman, AL | 1 |
| Davies, PD | 1 |
| Woodliff, HJ | 1 |
| Finlay-Jones, LR | 1 |
| Finley, R | 1 |
| Kieff, E | 1 |
| Thomsen, S | 1 |
| Fennessy, J | 1 |
| Beem, M | 1 |
| Lerner, S | 1 |
| Morello, J | 1 |
| Meschan, I | 1 |
| Hines, WB | 1 |
| Scharyj, M | 1 |
| Dunn, CD | 1 |
| Kuplic, JB | 1 |
| Higley, CS | 1 |
| Niewoehner, DE | 1 |
| Coury, C | 1 |
| Saltiel, JC | 1 |
| Zavala, DC | 1 |
| Bedell, GN | 1 |
| Rossi, NP | 1 |
| Littler, WA | 2 |
| Kay, JM | 2 |
| Hasleton, PS | 2 |
| Heath, D | 2 |
| Kirschner, RH | 1 |
| Esterly, JR | 1 |
| Kolarz, G | 1 |
| Pietsehmann, H | 1 |
| Regele, H | 1 |
| Brettner, A | 1 |
| Heitzman, ER | 1 |
| Woodin, WG | 1 |
| Rodin, AE | 1 |
| Haggard, ME | 1 |
| Travis, LB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Study Evaluating the Efficacy of the Allogeneic Hematopoietic Cell Transplantation With Antithymocyte Globulin (ATG)-Based Conditioning of Adult Acute Lymphoblastic Leukemia in First / Second Complete Hematologic Remission[NCT02428517] | 20 participants (Actual) | Observational | 2015-04-30 | Terminated (stopped due to The PI resigned the institute, and the rest investigators at the institute decided to terminate the study.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for busulfan and Disease, Pulmonary
| Article | Year |
|---|---|
Chemotherapy-induced lung disease.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Ble | 2004 |
Review: diagnosis of chemotherapy lung.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cy | 1981 |
Drug-induced pulmonary disease.
Topics: Amiodarone; Bleomycin; Busulfan; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Humans; Immu | 1995 |
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Topics: Alkylating Agents; Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carcinogens; Chemical a | 1975 |
Pulmonary reactions to drugs.
Topics: Adrenal Cortex Hormones; Aged; Aminoglycosides; Bleomycin; Busulfan; Contraceptives, Oral; Female; F | 1977 |
Pulmonary toxicity of antineoplastic drugs.
Topics: Antineoplastic Agents; Bleomycin; Busulfan; Cyclophosphamide; Humans; Lung Diseases; Methotrexate; N | 1978 |
Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents; Busulfan; Carcinogens; Centra | 1976 |
The spectrum of drug-induced pulmonary disease.
Topics: Adrenal Cortex Hormones; Aerosols; Analgesics; Aspirin; Autonomic Agents; Bleomycin; Busulfan; Contr | 1972 |
Drug-induced lung disease.
Topics: Anti-Bacterial Agents; Anticoagulants; Antihypertensive Agents; Bleomycin; Busulfan; Chlorpropamide; | 1973 |
The spectrum of diffuse pulmonary infiltration in malignant disease.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Busulfan; Embolism, Fat; Hemorrhage; Hodgkin Disease; Humans; I | 1973 |
Drug-induced lung disease.
Topics: Asthma; Busulfan; Contrast Media; Drug Hypersensitivity; Eosinophilia; Hexamethonium Compounds; Huma | 1969 |
The chemical and biological properties of busulphan ("Myleran").
Topics: Animals; Bone Marrow; Bone Marrow Cells; Busulfan; Cell Division; Cell Survival; Depression, Chemica | 1974 |
2 trials available for busulfan and Disease, Pulmonary
| Article | Year |
|---|---|
Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use.
Topics: Adult; Aged; Allografts; Busulfan; Disease-Free Survival; Female; Forced Expiratory Volume; Hematopo | 2019 |
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Topics: Adolescent; Adult; Alopecia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cycloph | 2001 |
31 other studies available for busulfan and Disease, Pulmonary
| Article | Year |
|---|---|
An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitution.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Female; Graft vs Host Disease; Hematologic Neopla | 2013 |
Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT.
Topics: Administration, Intravenous; Adult; Aged; Antilymphocyte Serum; Busulfan; Female; Follow-Up Studies; | 2014 |
Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.
Topics: Adolescent; Adult; Busulfan; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantatio | 2016 |
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality | 2006 |
[Drug-induced changes in the lungs].
Topics: Albumins; Bleomycin; Busulfan; Carmustine; Drug-Related Side Effects and Adverse Reactions; Humans; | 1984 |
Case record: Rhode Island Hospital.
Topics: Aged; Busulfan; Female; Humans; Leukemia, Myeloid; Lung Diseases; Pneumonia | 1983 |
Busulfan lung: cytologic diagnosis.
Topics: Busulfan; Female; Humans; Leukemia, Myeloid; Lung Diseases; Middle Aged; Respiratory Insufficiency | 1980 |
Early detection of busulfan lung: report of a case.
Topics: Busulfan; Female; Follow-Up Studies; Gallium; Humans; Leukemia, Myeloid; Lung Diseases; Middle Aged; | 1980 |
Miliary tuberculosis concurrent with busulfan lung.
Topics: Aged; Biopsy; Busulfan; Female; Humans; Leukemia, Myeloid; Lung Diseases; Tuberculosis, Miliary | 1982 |
Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Forced Expirator | 1995 |
Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
Topics: Actuarial Analysis; Adolescent; Adult; Bleomycin; Bone Marrow Transplantation; Busulfan; Child; Chil | 1995 |
Cytotoxic drug-induced lung disease.
Topics: Antibiotics, Antineoplastic; Azathioprine; Bleomycin; Busulfan; Cyclophosphamide; Dose-Response Rela | 1977 |
[Cytostatic agent induced lung disease].
Topics: Age Factors; Antineoplastic Agents; Bleomycin; Busulfan; Humans; Lung Diseases; Pulmonary Fibrosis; | 1978 |
[Drug-induced lung diseases].
Topics: Aspirin; Asthma; Bronchitis; Busulfan; Contraceptives, Oral, Hormonal; Dose-Response Relationship, D | 1979 |
Varied pulmonary lesions with intraalveolar large lamellar bodies in an autopsy case with busulfan therapy.
Topics: Busulfan; Female; Humans; Leukemia, Myeloid; Lung Diseases; Middle Aged; Pulmonary Alveoli | 1977 |
Cardiopulmonary dysfunctions caused by intravenous collagen-induced release of ADP and ATP from platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Busulfan; Central Venous Pr | 1975 |
Pulmonary alveolar proteinosis and disseminated atypical mycobacteriosis in a patient with busulfan lung.
Topics: Adult; Autopsy; Busulfan; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lung Disea | 1990 |
Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
Topics: Ambroxol; Animals; Antineoplastic Agents; Bleomycin; Bromhexine; Busulfan; Cyclophosphamide; Humans; | 1986 |
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; C | 1986 |
Busulphan lung.
Topics: Autopsy; Biopsy; Busulfan; Female; Humans; Leukemia, Myeloid; Lung; Lung Diseases; Male; Pulmonary A | 1972 |
Bronchial brushing in the diagnosis of pulmonary disease in patients at risk for opportunistic infection.
Topics: Aspergillosis; Bacterial Infections; Biopsy; Busulfan; Chickenpox; Coccidioidomycosis; Herpes Simple | 1974 |
Bronchopulmonary dysplasia--what is it?
Topics: Bronchial Diseases; Busulfan; Hodgkin Disease; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Mi | 1973 |
Pulmonary ossification associated with long-term busulfan therapy in chronic myeloid leukemia. Case report.
Topics: Autopsy; Busulfan; Female; Humans; Leukemia, Myeloid; Lung; Lung Diseases; Middle Aged; Ossification | 1972 |
[Pulmonary accidents following treatments with immunodepressive agents].
Topics: Antineoplastic Agents; Busulfan; Cough; Cyclophosphamide; Dyspnea; Immunosuppressive Agents; Lung Di | 1972 |
Trephine lung biopsy with a high-speed air drill. Results of 50 biopsies in 47 patients.
Topics: Adult; Aged; Biopsy; Busulfan; Female; Humans; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Male; | 1972 |
Busulphan lung.
Topics: Busulfan; Humans; Leukemia, Myeloid; Lung; Lung Diseases; Male; Microscopy, Electron; Middle Aged; P | 1969 |
Aetiology of pulmonary cholesterol-ester granulomas.
Topics: Busulfan; Cholesterol; Esters; Granuloma; Humans; Hypertension, Pulmonary; Leukemia, Myeloid; Lung; | 1970 |
Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Topics: Adult; Aged; Bronchial Diseases; Busulfan; Epithelium; Female; Humans; Hyperplasia; Leukemia, Myeloi | 1971 |
[Lung changes under busulfan therapy in a case of chronic myelosis].
Topics: Busulfan; Chronic Disease; Female; Humans; Leukocyte Count; Lung; Lung Diseases; Middle Aged; Primar | 1970 |
Pulmonary complications of drug therapy.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Busulfan; Child; Drug-Related Side Effects and Advers | 1970 |
Lung changes and chemotherapeutic agents in childhood. Report of a case associated with cyclophosphamide therapy.
Topics: Autopsy; Busulfan; Child, Preschool; Cortisone; Cyclophosphamide; Humans; Hyaline Membrane Disease; | 1970 |